Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Omnimmune Holdings Inc

+ Add to Watchlist

OMMH:US

0.0039 USD 0.00000.00%

As of 20:10:02 ET on 04/01/2015.

Snapshot for Omnimmune Holdings Inc (OMMH)

Open: 0.0039 Day's Range: 0.0039 - 0.0039 Volume: 5,000
Previous Close: 0.0039 52wk Range: 0.0039 - 0.0140 1-Yr Rtn: -

Stock Chart for OMMH

No chart data available.
  • OMMH:US 0.0039
  • 1D
  • 1M
  • 1Y
0.0039
Interactive OMMH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OMMH

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1900
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.04
Shares Outstanding (M) 9.36
30 Day Average Volume 167
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OMMH

No data available

Company Profile & Key Executives for OMMH

Omnimmune Holdings, Inc. is a holding company for a developing biotechnology company integrating complementary cancer therapeutic, diagnostic and prognostic technologies. The Company develops personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization) and gene-based products.

Mark S GermainChairmanHarris A LichtensteinPresident/CEO/CFO
Howard BeckerChief Operating OfficerAlexander Krichevsky "Alex"VP/Director:Research
More Company Profile & Key Executives for OMMH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil